Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: Current situation and future development

65Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered. © Higher Education Press and Springer-Verlag Berlin Heidelberg 2011.

Cite

CITATION STYLE

APA

Bian, Z., Liu, B., Moher, D., Wu, T., Li, Y., Shang, H., & Cheng, C. (2011, June 1). Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: Current situation and future development. Frontiers of Medicine in China. Higher Education Press Limited Company. https://doi.org/10.1007/s11684-011-0132-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free